stocks
GIANLIFE

Gian Life Care Ltd.

4.20-0.1 (-1.64%)
23 Oct, 12:00 AM

Stock Scores

Quality Score

Score not available

Value Score

Score not available

Price Momentum Score

Score not available

QVM Score

Score not available

Key Metrics

Market Cap
4.34
P/E (TTM)
-
P/B
0.23
P/S (TTM)
1.15
EV/EBITDA
-
CAPE (5Y)
1.66
ROE (TTM)
-4.84
ROCE (TTM)
-1.71
ROA (TTM)
-2.06
Avg 3Y ROE
-
Earnings 3Y CAGR
-
Sales 3Y CAGR
-
Sales 5Y CAGR
-
Debt/Equity
0.31
Consensus TP
-
Strong Buy %
-
Promoter Holding
-
Pledged %
-

Share Price

Track Gian Life Care Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.

4.20-0.1 (-1.64%)
-66.61% in past 1 year
1 Week returns: -7.49 %
Low
4.1
High
4.5
1 Month returns: -11.39 %
Low
4.1
High
4.8
1 Year returns: -66.75 %
Low
4.1
High
13.2
3 Year CAGR: -42.23 %
Low
4.1
High
29.0
5 Year CAGR: -
Low
4.1
High
65.9
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.

Stock Analysis

Fundamental analysis overview of Gian Life Care Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views
Red Flags
Positive
Company is net cash

The company is net cash i.e., cash and cash equivalents exceed total debt indicating a healthy balance sheet

What is Net Debt ?

Negative
Stock is fairly expensive with negative EPS on a trailing 12-month basis

Earnings yield of -21.95% indicates that the stock is very expensive and has a negative EPS on a trailing 12-month basis

What is Earnings yield (E/P)?

Low dividend yield

The company has a low dividend yield of 0.0%

What is Dividend yield?

Neutral
Not enough talking points with neutral stance
Thinly traded (low daily turnover)
The stock is thinly traded with combined (NSE & BSE) daily turnover (21-day average) of 0.00194796.

Financial Snapshot

See detailed analysis

Multi-year trends for Gian Life Care Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY
00k0k0k0k15.9 CrMar 202211.9 CrMar 202313.1 CrMar 20246.6 CrMar 2025
Profit After Tax FY
-0k00k0k0k4.4 CrMar 20221.1 CrMar 20234.2 CrMar 2024-0.0 CrMar 2025
ROE FY
-10%0%10%20%30%40%36.9%Mar 20227.3%Mar 202324.1%Mar 2024-0.2%Mar 2025
EBITDA FY
00k0k0k0k6.0 CrMar 20221.8 CrMar 20236.1 CrMar 20240.9 CrMar 2025

Gian Life Care Ltd. Shareholding Pattern

Quarterly breakdown of Gian Life Care Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

Mar 2020Sep 2020Mar 2021Sep 2021Mar 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Total Promoter
69.87
69.87
69.87
69.87
64.95
60.77
60.68
56.90
53.10
53.10
51.73
48.47
32.82
31.99
32.09
32.09
32.09
32.09
32.09
30.17
Indian Promoter
69.87
69.87
69.87
69.87
64.95
60.77
60.68
56.90
53.10
53.10
51.73
48.47
32.82
31.99
32.09
32.09
32.09
32.09
32.09
30.17
Foreign Promoter
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Institutions
-
-
-
-
-
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.01
0.01
0.01
0.01
0.01
0.01
Mutual Funds / UTI
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
FI/Bank/Insurance
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Govt
-
-
-
-
-
-
-
-
-
-
-
-
-
-
0.01
0.01
0.01
0.01
0.01
0.01
FII
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Institutions
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Non-Institution
30.13
30.13
30.13
30.13
35.05
39.23
39.32
43.10
46.90
46.90
48.27
51.53
67.18
68.01
67.90
67.90
67.90
67.90
67.90
69.82
Bodies Corporate
5.23
3.70
3.70
1.02
0.32
1.40
1.28
0.93
3.56
5.54
5.66
7.91
7.23
7.79
7.26
7.24
7.17
11.26
11.24
13.19
Others (incl. Retail)
No. of shareholders
24.90
53
26.43
55
26.43
55
29.11
74
34.73
274
37.83
482
38.04
511
42.17
1,075
43.34
1,320
41.36
2,084
42.61
2,075
43.62
2,414
59.95
3,334
60.22
3,843
60.64
4,280
60.66
4,364
60.73
4,347
56.64
4,269
56.66
4,202
56.63
4,229

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Gian Life Care Ltd. shares as reported to NSE and BSE.

NameMonthTransactionHolding % pre transactionAverage priceQty.Transaction value
ARUN KUMAR GUPTA
Promoter & Director
April-2024
Market Purchase (Acquisition)
8th Apr 2024
42.64 %₹ 26.804.80 lac₹ 1.29 cr
Arun Gupta
Promoter
March-2024
Market (Disposal)
4th Mar 2024
48.15 %₹ 24.055.70 lac₹ 1.37 cr
Arun Gupta
Promoter
July-2022
Market (Disposal)
19th Jul 2022
60.10 %₹ 28.0962.70 k₹ 17.61 lac
Arun Gupta
Promoter
July-2022
Market (Disposal)
11th Jul 2022
60.97 %₹ 27.9189.10 k₹ 24.87 lac
Arun Gupta
Promoter
July-2022
Market (Disposal)
2nd Jul 2022
61.35 %₹ 24.9539.60 k₹ 9.88 lac
Arun Gupta
Promoter
June-2022
Market (Disposal)
30th Jun 2022
61.99 %₹ 23.3566.00 k₹ 15.41 lac
Arun Gupta
Promoter
January-2022
Market (Disposal)
20th Jan 2022
62.21 %₹ 101.0010.50 k₹ 10.61 lac
Arun Gupta
Promoter
January-2022
Market (Disposal)
15th Jan 2022
64.99 %₹ 88.851.30 lac₹ 1.16 cr
Arun Gupta
Promoter
January-2022
Market (Disposal)
8th Jan 2022
66.90 %₹ 83.5090.00 k₹ 75.15 lac

Corporate Actions

History of Gian Life Care Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.

  1. Bonus6 new shares for 5 existing shares
    Ex-date: 29th Mar 2022Announced on: 14th Feb 2022

Company Profile

Overview of Gian Life Care Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Gian Life Care Limited is an India-based pathology provider. The Company is engaged in the business of providing diagnostic and related healthcare tests and services in various cities connecting Kanpur and nearby areas. The Company offers a range of approximately 1,344 tests, which includes various ...
Key personnel
Mrs. Avani Gupta
Chief Financial Officer
Mr. Vanshul Asnani
Compliance Officer, Company Secretary
Mr. Arun Kumar GuptaD
Managing Director, Executive Director
Mrs. Rashika AgarwalD
Non-Executive Woman Director
Mr. Shivam MamgainD
Non-Executive Director
Mr. Abhiram Saran AgarwalD
Non-Executive Independent Director
Mr. Umang GuptaD
Non-Executive Independent Director
Mr. Ramesh YadavD
Non-Executive Independent Director
Incorporated on
06 Nov 2018
Last Annual
31 Mar 2025
Last Interim
31 Dec 2025
No. of Employees
24
IPO date
13 Jan 2020
Free Float
47,55,414
Address
-

Frequently Asked Questions

What is the current share price of Gian Life Care Ltd.?
The current share price of Gian Life Care Ltd. is ₹ 4.20 as of 23 Oct 2026.
What is the market capitalisation of Gian Life Care Ltd.?
The market capitalisation of Gian Life Care Ltd. stands at ₹ 4.34 Cr.
What is the PE ratio of Gian Life Care Ltd.?
The Price-to-Earnings (PE) ratio of Gian Life Care Ltd. is - as of the latest trailing twelve months data.
What is the ROE and ROCE of Gian Life Care Ltd.?
Gian Life Care Ltd. has a Return on Equity (ROE) of -4.84% and a Return on Capital Employed (ROCE) of -1.71% as per the latest financial reports.
What is the 52-week high and low of Gian Life Care Ltd.?
The 52-week high of Gian Life Care Ltd. is - and the 52-week low is -.
What is the dividend yield of Gian Life Care Ltd.?
The dividend yield of Gian Life Care Ltd. is 0.00% based on the current market price.
What is the FII and DII holding in Gian Life Care Ltd.?
Foreign Institutional Investors (FII) hold -, Domestic Institutional Investors (DII) hold - of Gian Life Care Ltd. shares.
What sector does Gian Life Care Ltd. belong to?
Gian Life Care Ltd. operates in the Healthcare sector.
What is the beta of Gian Life Care Ltd.?
The beta of Gian Life Care Ltd. is 0.09, indicating its price volatility relative to the broader market. Over the past 1 year, Gian Life Care Ltd. has delivered an absolute return of -68.35%.
What is the RSI of Gian Life Care Ltd.?
The 14-day Relative Strength Index (RSI) of Gian Life Care Ltd. is 32.49, placing it approaching oversold territory. An RSI above 70 is considered overbought and below 30 is considered oversold.